Breaking News
Get 40% Off 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Hypertension Diagnostics Inc (HDII)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0001 0.0000    0.00%
08/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0000 - 0.0001
Hypertension Diagnostics 0.0001 0.0000 0.00%

Hypertension Diagnostics Inc Company Profile

 
Get an in-depth profile of Hypertension Diagnostics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

Hypertension Diagnostics, Inc. is a shell company. The Company through its wholly owned subsidiary China Specialty International Limited focuses on brand licensing, distribution authorization and investment related to these registered brands and trademarks in provincial-level, city-level, Country-level administrative regions in China.

Contact Information

Address 550 Highway 7 East Unit 316
Richmond Hill, L4B 3Z4
Canada
Phone 404-449-6151
Fax -

Top Executives

Name Age Since Title
Hans R. Brunner 84 - Member of Scientific & Clinical Advisory Board
Thomas D. Giles - - Member of Scientific & Clinical Advisory Board
Daniel Duprez - - Member of Scientific & Clinical Advisory Board
Larry Leitner 68 2003 Director
Jay N. Cohn 90 1988 Chairman of Scientific & Clinical Advisory Board
Stevo Julius - - Member of Scientific & Clinical Advisory Board
Michel E. Safar - - Member of Scientific & Clinical Advisory Board
Karl-Heinz Rahn - - Member of Scientific & Clinical Advisory Board
Giuseppe Mancia - - Member of Scientific & Clinical Advisory Board
Lawrence M. Resnick - - Member of Scientific & Clinical Advisory Board
Michael A. Weber - - Member of Scientific & Clinical Advisory Board
Marc Silver - - Member of Scientific & Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HDII Comments

Write your thoughts about Hypertension Diagnostics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Grégoire Jobin
Grégoire Jobin Sep 10, 2019 12:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$ACB fast profit !. . . The company’s preliminary results have set the stage for an increase in revenues. In addition, last June, the Edmonton-based grower that specializes in medicinal cannabis said it plans to expand into the consumer markets that includes concentrates and edibles. It will be interesting to see how investors will react.
Anonymous Quebec
Anonymous Quebec Sep 10, 2019 12:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they are way overextended, high debt, and just blew over a billion. id get out..lol
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email